Theralase Technologies Inc
XTSX:TLT
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.14
0.38
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Theralase Technologies Inc
Relative Value
The Relative Value of one
TLT
stock under the Base Case scenario is
0.29
CAD.
Compared to the current market price of 0.3 CAD,
Theralase Technologies Inc
is
Overvalued by 4%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
TLT Competitors Multiples
Theralase Technologies Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Theralase Technologies Inc
XTSX:TLT
|
71.8m CAD | 78 | -16.3 | -17.2 | -16.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
204.9B USD | 5 | 35.5 | 20.7 | 30.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
195.2B USD | 24.8 | 87 | 74.3 | 92.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
146.7B USD | 6.7 | 40.9 | 26.5 | 32.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
132.6B USD | 8.3 | 74 | 33.9 | 48.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.6B USD | 3.4 | 28.2 | 14.7 | 21 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
64.7B USD | 3.2 | 37.5 | 15.6 | 27.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
55.6B EUR | 2.5 | 29.8 | 17.1 | 24.9 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
319.2B CNY | 8.6 | 25.1 | 22.1 | 22.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
41.6B USD | 7.4 | 10 | 22.1 | 24.2 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
37.7B USD | 1.9 | 22.5 | 14 | 17.3 |
You don't have any saved screeners yet
